Dr. Earl P. Steinberg is a nationally known expert in population health management, data analytics, and clinical informatics. He has worked in academia, at a large payer and at a renowned integrated health care delivery system, has been a founder and CEO of two venture-backed start-ups and is a highly regarded health care consultant. Most recently, Dr. Steinberg spent 5-and-a-half years as the CEO of xG Health Solutions, a company formed by Geisinger Health System that has helped more than 80 health care delivery systems improve their clinical and financial performance.

From 2011 to 2015, Steinberg was executive vice president of innovation and chief, healthcare solutions enterprise at Geisinger. Prior to joining Geisinger, Steinberg, was senior vice president for clinical Strategy, quality & outcomes at WellPoint (now Anthem) and president and CEO of Resolution Health Inc. (RHI), a health care data analytics and intervention company he founded that was acquired by WellPoint. Prior to joining RHI, Dr. Steinberg spent six years as vice president of Covance Health Economics and Outcomes Services Inc., director of its quality assessment and improvement systems division, and co-director of its outcomes studies group, 12 years on the full-time faculty at The Johns Hopkins University, where he was professor of medicine and health policy and management and director of the Johns Hopkins Program for Medical Technology and Practice Assessment, four years on the Federal Physician Payment Review Commission and 20 years as a member of BCBS Association’s National Medical Advisory Panel. While at Covance, Steinberg led the teams that developed three HEDIS measures and helped develop a set of measures that are used to measure quality of care in all dialysis units in the U.S.

Steinberg currently is an independent consultant advising The Johns Hopkins University regarding its precision medicine initiative, serving as acting chief strategy officer at GNS Healthcare, an artificial intelligence company that leverages proprietary deep and causal learning techniques on behalf of pharma and biotech firms, as well health plans, and is a consultant to Dawnlight, a company with unique AI-driven device for monitoring patients at home. He also is on the scientific advisory board of Embold Health, a physician performance measurement company, and is an adjunct professor of medicine and health policy and management at The Johns Hopkins University. During April and part of May 2019 he was a visiting scholar at Stanford’s Clinical Excellence Research Center, where he focused on applications of artificial intelligence to health care.

Steinberg received his A.B. degree from Harvard College (summa cum laude), his MD from Harvard Medical School and a master’s of public policy from the Kennedy School of Government at Harvard. His residency training in internal medicine was performed at the Massachusetts General Hospital.

Steinberg has received numerous awards, including the Henry J. Kaiser Family Foundation Faculty Scholar Award in General Internal Medicine (1984), the “Outstanding Young Investigator” award from the Association for Health Services Research (1988) and a Special Presidential Visionary Award from the National Kidney Foundation (2004) for his work as the scientific director of NKF’s landmark Kidney Disease Outcomes and Quality Initiative, which produced over 250 clinical practice guidelines for management of patients with end stage renal disease. He also is a fellow of both the American College of Physicians and Academy Health and has published more than 135 articles in peer-reviewed journals.